Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma

NCT05097287 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05097287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05097287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Active, not recruiting
Start date
December 16, 2021
Completion date
June 8, 2029
Enrollment
1,339 (actual)
Sites
249

Conditions

As the registry lists them; a condition with its own page is linked.

asthma